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Background: Acute kidney injury (AKI) is one of the major complications of Plasmodium falciparum malaria,
especially among non-immune adults. It has recently been revealed that activation of transcription factor nuclear
factor kappa B (NF-κB) induces pro-inflammatory gene expression involved in the development of progressive renal
inflammatory diseases. The aim of this study was to determine whether urinary sediment NF-κB p65 can act as a
biomarker for AKI in patients with P. falciparum malaria.
Methods: Urinary sediments from malaria patients, including Plasmodium vivax malaria, uncomplicated P. falciparum
malaria, complicated P. falciparum malaria without AKI (serum creatinine-Cr <3 mg/dl) and complicated P. falciparum
malaria with AKI (Cr ≥3 mg/dl) were used to determine NF-κB p65 level by sandwich enzyme-linked immunosorbent
assay (ELISA). Urinary sediments obtained from healthy controls were used as a normal baseline. Correlations between
levels of urinary sediment NF-κB p65 and pertinent clinical data were analysed.
Results: Urinary sediment NF-κB p65 levels were significantly increased on the day of admission (day 0) and on day 7
post-treatment in complicated P. falciparum malaria patients with AKI, compared with those without AKI (p = 0.001,
p <0.001, respectively), P. vivax patients (all p <0.001) and healthy controls (all p <0.001). NF-κB p65 levels in urinary
sediment cells showed a significant positive correlation with serum Cr (Day 0: rs = 0.792; p <0.001, Day 7: rs = 0.605;
p <0.001) and blood urea nitrogen (BUN) (Day 0: rs = 0.839; p <0.001, Day 7: rs = 0.596; p <0.001).
Conclusions: Urinary sediment NF-κB p65 level is a useful indicator for estimating renal tubular epithelial cell damage
and subsequent development of AKI among patients with P. falciparum malaria.
Keywords: Malaria, Plasmodium falciparum, Nuclear factor kappa B (NF-κB), Urinary sediment, Acute kidney injury (AKI)Background
Acute kidney injury (AKI) is one of the serious compli-
cations of Plasmodium falciparum infection, with mor-
tality rates as high as 70% among untreated patients [1].
The rare incidence has also been reported in Plasmodium
vivax, occasionally contributing to renal impairment [2].
Malarial AKI is more common among adults in tropical
areas where transmission of malaria is low or unstable and
where the disease occurs at all ages [3]. Clinical presenta-
tions of malarial AKI patients are usually oliguria with* Correspondence: parnpen.vir@mahidol.ac.th
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article, unless otherwise stated.increasing levels of serum creatinine (Cr), but urine
output may also be normal [3]. Several factors have been
implicated in the pathogenesis of malarial AKI, includ-
ing the cyto-adherence of parasitized red blood cells
(PRBCs), the effect of various chemical mediators, dehy-
dration, intravascular haemolysis, and hyperparasitaemia
[4]. Studies on Southeast Asian adults dying from severe
falciparum malaria have indicated that the frequency of
PRBC sequestration in the renal blood vessels of patients
dying from AKI was significantly higher than those without
AKI [5,6].
AKI is generally characterized by the sudden loss of
the kidneys’ ability to concentrate urine, excrete waste,
conserve electrolytes, and maintain fluid balance. The
disease is associated with a mortality rate of between 50ioMed Central Ltd. This is an Open Access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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detected by the measurement of serum Cr or by a rise in
blood urea nitrogen (BUN). BUN is a non-specific indi-
cator of renal function as urea production can be altered
by dehydration, food intake and tissue catabolism [3].
Thus, serum Cr is more specific in assessing renal func-
tion than BUN [8]. In general, it has been approximated
that the incidence of AKI in the intensive care unit was
about 1-25% and the mortality rate was 15-60% [9]. In
Thailand, the incidence of AKI in P. falciparum malaria
varies from 0.14-0.18% at the Hospital for Tropical Dis-
eases, Bangkok [10] and up to 73.9% at Mae Sot General
Hospital using RIFLE criteria (risk, injury, failure, loss,
and end-stage kidney disease) [11]. Existing kidney
markers such as serum Cr, urine output, and estimated
glomerular filtration rate, become elevated only when a
significant damage or loss of kidney function has occurred.
Recently, urinary biomarkers such as interleukin-18
(IL-18), kidney injury molecule-1 (KIM-1) and neutrophil
gelatinase-associated lipocalin (NGAL) have been reported
as non-invasive and relatively inexpensive tools for asses-
sing the degree and characteristics of inflammation and
tubulo-interstitial damage [12,13]. Several studies have
demonstrated that nuclear factor-κB (NF-κB) is activated
in the renal tubular epithelial cells, glomeruli and urothe-
lial cells in renal injury [14,15] and that renal inflamma-
tion can occur after induction by a variety of stimuli
[14,15]. NF-κB is a family of dimeric transcription factors
that regulates the expression of numerous genes involved
in inflammation and cell proliferation [16]. The increased
activation of NF-κB may indicate a response to renal tubu-
lar injury [14,15].
This study investigated NF-κB p65 levels in urinary
sediments from malaria patients to assess whether urin-
ary sediments NF-κB p65 can serve as a sensitive tool
for detecting AKI in P. falciparum malaria patients.
Methods
Subjects
Thirty-nine malaria patients admitted to the Hospital for
Tropical Diseases, Faculty of Tropical Medicine, Mahidol
University, Thailand were enrolled into this study. Classifi-
cation of malaria species was based on microscopic identi-
fication. The patients were divided into four groups: 1)
P. vivax malaria (n = 11), 2) uncomplicated P. falciparum
malaria (n = 8), 3) complicated P. falciparum malaria with-
out AKI (Cr <3 mg/dl) (n = 10), and, 4) complicated
P. falciparum malaria with AKI (Cr ≥3 mg/dl) (n = 10).
Classification of complicated P. falciparum malaria was
based on WHO criteria [3]. The control group consisted
of 14 healthy volunteers living in Bangkok, a non-endemic
malaria area. This group had no history of malaria infec-
tion. This study was approved by the Ethics Committee,
Faculty of Tropical Medicine, Mahidol University (MUTM2010-035-01, MUTM 2010-035-02). Written informed
consent was obtained from all patients or their legal repre-
sentatives before enrollment into the study.
Blood and urine samples
Five ml of whole blood were obtained from malaria
patients on day 0 (pre-treatment) and day 7 (post-
treatment). Samples of clotted blood were centrifuged at
1,700 g for 10 min and the serum was harvested and
stored in an aliquoted state at -70°C. The serum was
used to measure Cr and BUN levels to investigate kidney
function. Urinary sediment NF-κB p65 was determined
by enzyme-linked immunosorbent assay (ELISA). Early
morning whole-stream urine specimens were collected
from all subjects on day 0 (pre-treatment) and day 7
(post-treatment). For urine sediment preparation, urine
samples were centrifuged at 3,000 g for 15 min and urin-
ary cell pellets were collected and stored at -70°C until
use. The proteins from urinary cell pellets were ex-
tracted by lysis buffer (Cell Signaling, MA, USA) con-
taining protease inhibitors (Sigma-Aldrich, MO, USA)
according to the manufacturers’ protocol. In summary,
the pellets were sonicated on ice, centrifuged at 14,000 g
for 10 min at 4°C and the supernatants were harvested
and used for ELISA. Protein concentrations were deter-
mined by Bradford assay (Pierce Biotechnology, IL, USA),
using bovine serum albumin (BSA) as the standard.
Fifteen ml of urine sample were sent to the laboratory
immediately or stored at 4°C overnight for urine analysis.
Measurement of urinary sediment NF-κB p65 levels
The NF-κB p65 levels in urinary sediments were measured
by sandwich ELISA kit (Cell Signaling, MA, USA) accord-
ing to the manufacturer’s protocol. Phospho-NF-κB p65
mouse monoclonal antibody diluted to 1: 100 in PBS was
coated on a 96-well microplate and stored overnight. Pro-
tein samples (45 μg/well) were added and incubated for
two hours at 37°C. The plate was then washed with PBS
containing 0.05% (w/v) Tween-20 (PBS-T). Phospho-NF-
κB p65 rabbit monoclonal antibody was added to the wells
and incubated for one hour at 37°C to detect the captured
phospho-NF-κB p65 protein. After washing with PBS-T,
anti-rabbit IgG secondary antibody conjugated with horse-
radish peroxidase (HRP) was added and incubated for
30 min at 37°C. The colour reaction was developed by
incubation with 3,3′,5,5′ tetramethylbenzidine (TMB)
substrate solution (Cell Signaling, MA, USA). Finally, the
reaction was stopped with 0.18 M sulphuric acid. Optical
density (OD) was measured at 450 nm. All assays were
carried out in duplicate.
Statistical analysis
Statistical analysis was performed using SPSS version
17.0 software (SPSS, IL, USA). All results were presented
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normality of distribution was determined by the
Kolmogorov-Smirnov test. Differences in levels of urin-
ary sediment NF-κB p65 between groups were compared
by Mann-Whitney U-test. Differences in levels of urinary
sediment NF-κB p65 within groups between day 0 and
day 7 were tested by Wilcoxon signed-rank test. In
addition, the correlation between levels of NF-κB p65
and pertinent clinical data including age, malaria para-
site density, haemoglobin, haematocrit, white blood cells
(WBC) and urinary laboratory parameters were calcu-
lated using Spearman’s rank correlation (rs). A p value
<0.05 was considered statistically significant.
Results
Clinical and laboratory data of malaria patients
Clinical data of the malaria patients and healthy controls
are shown in Table 1 and the results of urinary analysis
are presented in Table 2. On admission, the mean mal-
aria parasite density in the group of complicated P.
falciparum malaria patients without AKI (Cr <3 mg/dl)
(670,124 parasite/μl) was similar to those with AKI
(Cr ≥3mg/dl) (547,766 parasite/μl) (p = 0.602). At day 7
post-treatment, no asexual form of malaria parasite was
found in the peripheral blood of any malaria patient. A
significant increase in the level of serum Cr was found
in the group of complicated P. falciparum malaria
patients with AKI (6.3 ± 0.5 mg/dl), compared with
complicated P. falciparum malaria patients without AKI
(1.8 ± 0.2 mg/dl) (p = 0.009). The Cr level was 3.5 times
higher in malaria patients with AKI. No significant
difference in serum Cr was found in P. vivax patients (0.8
± 0.1 mg/dl) and uncomplicated P. falciparum patients
(0.9 ± 0.1 mg/dl), compared with the healthy controls
upon admission and day 7 post-treatment (all p >0.05).
Serum BUN was also significantly higher in P. falciparumTable 1 Demographic data and clinical data of malaria patien
P. vivax P. falciparum
uncomplicated
n 11 8
Age (year) 24 ± 2.6 27 ± 2.8
Sex (male:female) 11:0 8:0
Parasite (μl) D0 20,376a, b 249,101a, b
Parasite (μl) D7 0c 0c
Serum Cr D0 0.8 ± 0.1b 0.9 ± 0.1b
Serum Cr D7 0.8 ± 0.3b 0.8 ± 0.6b
Serum BUN D0 13.4 ± 1.0b 15.9 ± 2.2b
Serum BUN D7 12.6 ± 0.8b 12.4 ± 1.3b
aSignificance of p <0.05 compared with healthy controls.
bSignificance of p <0.05 compared with P. falciparum malaria associated with AKI (C
cSignificance of p <0.05 compared with the day of admission.malaria with AKI than in P. vivax, uncomplicated P.
falciparum and P. falciparum malaria patients without
AKI (all p <0.05).
All malaria patient groups showed higher proteinuria
than the healthy controls upon admission (all p <0.05).
Proteinuria was significantly increased in complicated
P. falciparum (both with and without AKI groups), com-
pared with P. vivax and uncomplicated P. falciparum
(all p <0.05) (Table 2). The number of red blood cells
(RBC) in the urine was significantly increased in all mal-
aria groups compared with healthy controls upon admis-
sion (all p <0.05). Significantly lower RBC numbers were
observed in P. vivax and uncomplicated P. falciparum,
compared with complicated P. falciparum (both with
and without AKI groups) (all p <0.05). In addition, the
mean number of WBC in the urine sediment was high-
est in the group of complicated P. falciparum malaria
with AKI compared with the healthy controls (p <0.001),
P. vivax, uncomplicated P. falciparum and P. falciparum
malaria patients without AKI (all p <0.05). At day 7, the
microscopic levels of RBC, WBC and epithelial cells
remained significantly elevated in the urine samples from
complicated P. falciparum malaria with AKI patients,
compared to the healthy controls (p = 0.02, p = 0.001 and
p <0.001, respectively) (Table 2).
NF-κB p65 level in urinary sediment cells
NF-κB p65 levels measured by ELISA in the urinary
sediment cells of malaria patients and healthy controls
are shown in Figure 1. On admission (day 0), the mean
level urinary sediment NF-κB p65 was significantly ele-
vated in complicated P. falciparum malaria with AKI
(0.47 ± 0.02), compared with P. vivax malaria (0.21 ±
0.02), uncomplicated P. falciparum malaria (0.27 ± 0.02)
and complicated P. falciparum malaria without AKI













1.8 ± 0.2a, b 6.3 ± 0.5a 0.8 ± 0.0
0.7 ± 0.5b, c 8.6 ± 0.2a, c 0.9 ± 0.1
32.6 ± 4.7b 109.4 ± 14.0 NA
12.8 ± 0.8b, c 75.6 ± 0.5c NA
r ≥3 mg/dl).
Table 2 Urine analysis of malaria patients and healthy controls







(Cr ≥ 3.0 mg/dl)
Healthy controls
n 11 8 10 10 14
Specific gravity D0 1.017 ± 0.0a, b 1.017 ± 0.0a 1.021 ± 0.0a 1.021 ± 0.0a 1.010 ± 0.0
Specific gravity D7 1.021 ± 0.0a 1.015 ± 0.0b 1.022 ± 0.0a 1.021 ± 0.0a 1.010 ± 0.0
pH D0 6.8 ± 0.3b 6.1 ± 0.2b 5.6 ± 0.3a, b 5.0 ± 0.0a 6.6 ± 0.2
pH D7 5.6 ± 0.2a, b, c 6.0 ± 0.3 6.2 ± 0.1 6.2 ± 0.1c 6.3 ± 0.2
Urine protein D0 27.3 ± 9.8a, b 43.8 ± 12.3a, b 62.0 ± 17a 160.0 ± 56.7a 0 ± 0.0
Urine protein D7 4.5 ± 3.0 3.1 ± 3.1c 0 ± 0.0c 6.0 ± 4.0c 0 ± 0.0
RBC in Urine D0 0.7 ± 0.3a, b 0.5 ± 0.3a, b 3.4 ± 1.1a 11.8 ± 6.4a 0 ± 0.0
RBC in Urine D7 0.1 ± 0.1b 0 ± 0.0b 0 ± 0.0b, c 6.4 ± 3.9a 0 ± 0.0
WBC in Urine D0 0.8 ± 0.3b 1.6 ± 0.5b 1.6 ± 0.2a, b 2.4 ± 0.2a 1.0 ± 0.0
WBC in Urine D7 1.1 ± 0.1b 1.0 ± 0.0b 2.4 ± 0.2a, b, c 3.8 ± 0.3a, c 1.3 ± 0.2
Epithelium D0 1.1 ± 0.1b 1.6 ± 0.3b 1.6 ± 0.4b 5.0 ± 1.0a 1.1 ± 0.1
Epithelium D7 1.1 ± 0.1b 1.0 ± 0.0b 3.0 ± 0.6a, b, c 10.6 ± 1.3a, c 1.2 ± 0.2
aSignificance of p <0.05 compared with healthy controls.
bSignificance of p <0.05 compared with P. falciparum malaria associated with AKI (Cr ≥3 mg/dl).
cSignificance of p <0.05 compared with the day of admission.
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level of urinary sediment NF-κB p65 increased signifi-
cantly in the groups of complicated P. falciparum mal-
aria with and without AKI (all p <0.001). However,
P. vivax malaria patients showed a significant decrease
in urinary sediment NF-κB p65 level compared with
healthy controls (p = 0.019), while NF-κB p65 levels in
uncomplicated P. falciparum malaria patients were similar
to the healthy controls (p >0.05).
On day 7 post-treatment, the NF-κB p65 levels in the
urinary sediment cells were significantly increased in
both groups of complicated P. falciparum malaria








Healthy controls P. vivax P. fa
unco







Figure 1 Levels of NF-κB p65 in the urinary sediment cells of malaria
sediment cells was used to measure the level NF-κB p65 by ELISA. *Signific
compared with P. falciparum malaria associated with AKI (Cr ≥3 mg/dl).0.02), compared with the healthy controls (0.25 ± 0.01;
p = 0.001, p <0.001, respectively). Among the compli-
cated P. falciparum malaria, AKI group showed signifi-
cantly higher urine NF-κB p65 levels, compared to
those without AKI (p <0.05). In addition, the level of
urinary sediment NF-κB p65 remained significantly
decreased in patients infected with P. vivax malaria
(0.19 ± 0.02), compared with the healthy controls (p =
0.014). The lowest levels of urinary sediment NF-κB p65
were found in P. vivax malaria patients. However, no sig-
nificant differences in the levels of urine NF-κB p65 were
observed between day 0 and day 7 in all malaria patient





(Cr < 3 mg%)
P.falciparum
complicated
(Cr ≥ 3 mg%)
**
* *
*, ** *, **
patients and healthy controls. Protein isolated from the urinary
ance of p <0.05 compared with healthy control. **Significant of p <0.05
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and clinical data
On admission, NF-κB p65 levels in the urinary sediment
cells showed significant positive correlations with serum
Cr (rs = 0.792; p <0.001), BUN (rs = 0.839; p <0.001),
parasite density (rs = 0.737; p <0.001) and microscopic
WBC (rs = 0.550; p <0.001) (Figure 2). On day 7 post-
treatment, NF-κB p65 showed significantly positive
correlations with serum Cr (rs = 0.605; p <0.001), BUN
(rs = 0.596; p <0.001), microscopic WBC (rs = 0.820;
p <0.001) and urinary epithelial cells (rs = 0.865; p <0.001)
(Figure 3).
Within the complicated P. falciparum malaria with
AKI group, a significant positive correlation was found
between NF-κB p65 in the urinary sediment cells and
serum Cr. on the day of admission (rs = 0.9000; p = 0.037)
and on day 7 post-treatment (rs = 0.975; p <0.005). There
was no significant correlation between NF-κ B p65 levels
in the urinary sediment cells and other urinary parameters
including specific gravity, pH and urine protein in any
malaria patient group.
Discussion
The precise mechanism of AKI in P. falciparum malaria
has not been fully understood. Several hypotheses have
been demonstrated including mechanical obstruction
by infected PRBCs, immune mediated glomerular
pathology, fluid loss due to multiple mechanisms and
alterations in renal microcirculation [4,17,18]. The histo-
pathological finding in malaria AKI showed a variable
mixture of acute tubular necrosis (ATN), interstitial
nephritis and glomerulonephritis. ATN is the most
























rs = 0.737; p < 0.001











Figure 2 Correlations between urinary sediment NF-κB p65 and clinic
Spearman’s rank correlation.swelling, hemosiderin granular deposits and cell necrosis
[4]. An ultrastructural study of the kidney in fatal falcip-
arum malaria showed PRBC sequestration in the glom-
erular and tubulo-interstitial blood vessels; and acute
tubular damage is an important feature [6]. With regard
to chemical mediators, inflammatory cells, particularly
monocytes stimulated by glycosylphosphatidylinositol,
can enhance the synthesis of various cytokine cascades
and mediators. These mediators cause changes in blood
volume status, vasodilation and increases vascular per-
meability leading to hypovolaemia which can contribute
to ischemic renal failure [17]. Activation of NF-κB in
renal tubular epithelial cells and macrophages in human
renal tissues has been reported [14]. In the present
study, NF-κB p65 levels in urinary sediment cells were
highest and remained significantly elevated from pre-
treatment to day 7 post-treatment in complicated P.
falciparum malaria associated with AKI (Cr ≥3 mg/dl),
compared with healthy controls and other malaria
groups. It is possible that activation of NF-κB p65 in the
urine sediment containing renal epithelial cells and
WBC is triggered by various ligands or proteins of mal-
aria parasites that induce up-regulation of the NF-κB
p65 signalling pathway. This eventually leads to nuclear
translocation of NF-κB and regulation of gene expres-
sion involved in inflammation and apoptosis. The in-
flammation in the interstitium of kidney tissue has been
proposed to play a major role in the pathophysiology of
AKI [19,20]. A study also reported that proximal tubular
epithelial cells are an important source of cytokine
production, such as interleukin (IL)-18 and IL-16. These
cytokines enter the interstitium and result in activation
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Figure 3 Correlations between urinary sediment NF-κB p65 and clinical data on day 7 post-treatment (n = 39). Data analysed by Spearman’s
rank correlation coefficient.
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http://www.malariajournal.com/content/13/1/84In this study, ELISA was used to measure NF-κB p65
levels in urinary sediment cells. Preliminary experiments
using urine supernatants from malaria patients were
unable to detect NF-κB p65. Either NF-κB p65 was not
excreted into the urine or the molecule was too diluted
within the urine to be measurable directly. Similar find-
ing was documented for urinary haem oxygenese-1
(uHO-1) measurement, where it was undetectable in the
urine supernatant [22]. Activation of NF-κB p65 has
been demonstrated in glomeruli, in tubulo-interstitial
cells, in infiltrating cells of obstructed kidneys [23], as
well as in renal tubular cells [14]. The proximal and
distal tubular epithelial cells were documented as major
NF-κB p65 producers [22]. Recent studies show that
NF-κB p65 activation has also been detected in periph-
eral blood mononuclear cells (PBMCs) from complicated
P. falciparum malaria patients [24]. The source of NF-
κB p65 in urine sediment possibly originated from renal
tubular cells, which were detached from the basement
membrane into the lumen of renal tubules and/or from
the WBC. Both renal epithelial cells and WBC were
found upon examination under a light microscope. The
NF-κB p65 levels may indicate ongoing renal damage
after infection with malaria. Complicated P. falciparum
malaria without AKI also showed a rise in NF-κB p65
levels, compared to healthy controls, but was signifi-
cantly lower than AKI group (Figure 1). Data suggest
that NF-κB p65 levels may reflect the degree of renal
tubular damage caused by PRBC sequestration, leading
to restricted local blood flow and host cytokine response,
contributing to progressive renal tubular injury.
AKI is usually diagnosed by increased serum Cr or
BUN levels. Newer biomarkers have been used for theearly diagnosis of AKI, such as IL-18, KIM-1 and NGAL
[25]. This study documented a potential role of NF-κB
p65 level in urinary sediment cells in assessing AKI in
malaria patients. Within the group of complicated P.
falciparum malaria associated with AKI, a significant
positive correlation was found between NF-κB p65 in
the urinary sediment cells and serum Cr on the day of
admission (rs = 0.9000; p = 0.037) and on day 7 post-
treatment (rs = 0.975; p <0.005). However, lower urinary
NF-κB p65 levels were detected in P. vivax and uncom-
plicated P. falciparum patients. Therefore, NF-κB p65
may be a valuable indicator of renal cell damage and the
subsequent development of AKI in malaria patients.
Although, the results show clear statistical significance, a
larger sample size and serial determination of urinary
NF-κB p65 levels can further address its benefit over
serum Cr level.
NF-κB p65 levels in urinary sediment cells showed a
significant positive correlation with serum Cr on the day
of admission and day 7 post-treatment. It has been
reported that increased serum Cr was the major factor
and an important predictor for mortality among malaria
patients with AKI, and that early diagnosis and prompt
management including dialysis can reduce mortality
[26]. A positive correlation was found between NF-κB
p65 levels and parasite density on day of admission. This
finding can be associated with a higher risk of develop-
ing malaria AKI, as previous study has shown that
patients with parasitaemia >5%, corresponding to 250,000
PRBCs per μl were at higher risk of developing malaria
AKI than those with lower parasitaemia [27]. In addition,
NF-κB p65 showed a significant positive correlation
with microscopic WBC on day of admission and day 7
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tion of NF-κB p65 reported in the PBMCs of malaria
patients [24].Conclusions
The levels of NF-κB p65 in urinary sediment cells reflect
the degree of damage in renal tubular epithelial cells in
malaria patients. Therefore, the urinary level of NF-κB
p65 has a potential role as a disease biomarker in esti-
mating damage to renal tubular epithelial cells and
subsequent progression of AKI among complicated
P. falciparum malaria patients. It will be useful to inves-
tigate the NF-κB p65 expression level in specific cell
types in urinary sediments, to further explore the exact
precursor cells of NF-κB and establish its role in the
pathogenesis of AKI in malaria.
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